Literature DB >> 9785067

Cardiovascular responses, arterial oxygen saturation and plasma catecholamine concentration during upper gastrointestinal endoscopy using conscious sedation with midazolam or propofol.

V L Oei-Lim1, C J Kalkman, J F Bartelsman, J C Res, H B van Wezel.   

Abstract

Hypoventilation as a consequence of deep intravenous sedation is the most frequently reported cause of cardiac arrest during upper gastrointestinal endoscopy (UGIE). Haemodynamic stress can contribute to myocardial ischaemia; therefore, this study was designed to observe prospectively the cardiorespiratory changes during UGIE using either midazolam or propofol for conscious sedation. Thirty-four patients, aged 50 years and older, ASA physical status I-III, scheduled for elective UGIE with sedation, were studied. Oxygen saturation, heart rate, non-invasive blood pressure and Holter ECG were recorded continuously starting 15 min before sedation until 15 min after the endoscopy. In addition, plasma catecholamine concentrations were determined. The results of this study are consistent with previous reports that cardiopulmonary events may occur during endoscopy, with or without sedation. Both midazolam and propofol sedation may provide some protection against haemodynamic stress in response to insertion and manipulation of the endoscope, but sedation can also contribute to the occurrence of hypoxaemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9785067     DOI: 10.1046/j.1365-2346.1998.00349.x

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  10 in total

1.  Case of Vasovagal Syncope With Asystole Associated With Propofol Sedation.

Authors:  Keiko Fujii-Abe; Kazutaka Uriu; Hiroshi Kawahara
Journal:  Anesth Prog       Date:  2015

2.  Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injection.

Authors:  Shinsuke Kiriyama; Takuji Gotoda; Hiromi Sano; Ichiro Oda; Fumiya Nishimoto; Tetsuro Hirashima; Chika Kusano; Hiroyuki Kuwano
Journal:  J Gastroenterol       Date:  2010-03-13       Impact factor: 7.527

3.  Esophagoduodenoscopy or colonoscopy: which should be done first?

Authors:  Pınar Sayın; Özgür Bostancı; Hacer Şebnem Türk; Canan Tülay Işıl; Sibel Oba; Mehmet Mihmanlı
Journal:  Turk J Surg       Date:  2020-06-08

4.  Propofol versus Midazolam for Sedation during Esophagogastroduodenoscopy in Children.

Authors:  Ji Eun Oh; Hae Jeong Lee; Young Hwan Lee
Journal:  Clin Endosc       Date:  2013-07-31

5.  Cardiorespiratory changes during upper gastrointestinal endoscopy.

Authors:  B B Osinaike; A Akere; T O Olajumoke; E O Oyebamiji
Journal:  Afr Health Sci       Date:  2007-06       Impact factor: 0.927

6.  Propofol versus midazolam for upper gastrointestinal endoscopy in cirrhotic patients: a meta-analysis of randomized controlled trials.

Authors:  Hsiao-Chien Tsai; Yu-Cih Lin; Ching-Lung Ko; Horng-Yuan Lou; Ta-Liang Chen; Ka-Wai Tam; Chien-Yu Chen
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

7.  Clinical efficacy of high-flow nasal oxygen in patients undergoing ERCP under sedation.

Authors:  Boram Cha; Man-Jong Lee; Jin-Seok Park; Seok Jeong; Don Haeng Lee; Tae Gyu Park
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

8.  Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients.

Authors:  Astrid Kerker; Christian Hardt; Hans-Eugen Schlief; Franz Ludwig Dumoulin
Journal:  BMC Gastroenterol       Date:  2010-01-27       Impact factor: 3.067

9.  The use of propofol as a sedative agent in gastrointestinal endoscopy: a meta-analysis.

Authors:  Daorong Wang; Chaowu Chen; Jie Chen; Yaxiang Xu; Lu Wang; Zhen Zhu; Denghao Deng; Juan Chen; Aihua Long; Dong Tang; Jun Liu
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

10.  A Response Surface Model Exploration of Dosing Strategies in Gastrointestinal Endoscopies Using Midazolam and Opioids.

Authors:  Jing-Yang Liou; Chien-Kun Ting; Ming-Chih Hou; Mei-Yung Tsou
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.